Though few cytokine and growth factor studies have been conducted on sarcomas, some research has documented elevated serum levels of VEGF, IL-2 and bFGF in sera of patients with soft tissue sarcomas (17,18); VEGF serum levels correlated significantly with tumor size and histological grade (17). This evidence concerns the gene IL2 and soft tissue sarcoma.